Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling

Abstract

Antiestrogens include agents such as tamoxifen, toremifene, raloxifene, and fulvestrant. Currently, tamoxifen is the only drug approved for use in breast cancer chemoprevention, and it remains the treatment of choice for most women with hormone receptor positive, invasive breast carcinoma. While antiestrogens have been available since the early 1970s, we still do not fully understand their mechanisms of action and resistance. Essentially, two forms of antiestrogen resistance occur: de novo resistance and acquired resistance. Absence of estrogen receptor (ER) expression is the most common de novo resistance mechanism, whereas a complete loss of ER expression is not common in acquired resistance. Antiestrogen unresponsiveness appears to be the major acquired resistance phenotype, with a switch to an antiestrogen-stimulated growth being a minor phenotype. Since antiestrogens compete with estrogens for binding to ER, clinical response to antiestrogens may be affected by exogenous estrogenic exposures. Such exposures include estrogenic hormone replacement therapies and dietary and environmental exposures that directly or indirectly increase a tumor's estrogenic environment. Whether antiestrogen resistance can be conferred by a switch from predominantly ERα to ERβ expression remains unanswered, but predicting response to antiestrogen therapy requires only measurement of ERα expression. The role of altered receptor coactivator or corepressor expression in antiestrogen resistance also is unclear, and understanding their roles may be confounded by their ubiquitous expression and functional redundancy. We have proposed a gene network approach to exploring the mechanistic aspects of antiestrogen resistance. Using transcriptome and proteome analyses, we have begun to identify candidate genes that comprise one component of a larger, putative gene network. These candidate genes include NFκB, interferon regulatory factor-1, nucleophosmin, and the X-box binding protein-1. The network also may involve signaling through ras and MAPK, implicating crosstalk with growth factors and cytokines. Ultimately, signaling affects the expression/function of the proliferation and/or apoptotic machineries.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Aamdal S, Bormer O, Jorgensen O, Host H, Eilassen G, Kaalhus O and Pihl A . (1984). Cancer, 53, 2525–2529.

  • Adlercreutz H . (1995). Environ. Health Persp., 103, 103–112.

  • Agarwal R . (2000). Biochem. Pharmacol., 60, 1051–1059.

  • Alberts SR, Ingle JN, Roche PR, Cha SS, Wold LE, Farr Jr GH, Krook JE and Wieand HS . (1996). Cancer, 78, 764–772.

  • Allred CD, Allred KF, Ju YH, Virant SM and Helferich WG . (2001). Cancer Res., 61, 5045–5050.

  • Anzano MA, Byers SW, Smith JM, Peer CW, Mullen LT, Brown CC, Roberts AB and Sporn MB . (1994). Cancer Res., 54, 4614–4617.

  • Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, Guan X-Y, Sauter G, Kallioniemi O-P, Trent JM and Meltzer PS . (1997). Science, 277, 965–968.

  • Atanaskova N, Keshamouni VG, Krueger JS, Schwartz JA, Miller F and Reddy KB . (2002). Oncogene, 21, 4000–4008.

  • Azorsa DO, Cunliffe HE and Meltzer PS . (2001). Breast Cancer Res. Treat., 70, 89–101.

  • Bachleitner-Hofmann T, Pichler-Gebhard B, Rudas M, Gnant M, Taucher S, Kandioler D, Janschek E, Dubsky P, Roka S, Sporn E and Jakesz R . (2002). Clin. Cancer Res., 8, 3427–3432.

  • Baldwin Jr AS . (2001). J. Clin. Invest., 107, 3–6.

  • Barnes S, Peterson G, Grubbs C and Setchell K . (1994). Diet and Cancer: Markers, Prevention, and Treatment. Jacobs MM (ed). Plenum Press: New York, pp. 135–147.

    Book  Google Scholar 

  • Barton DL, Loprinzi CL, Quella SK, Sloan JA, Veeder MH, Egner JR, Fidler P, Stella PJ, Swan DK, Vaught NL and Novotny P . (1998). J. Clin. Oncol., 16, 495–500.

  • Bautista S, Valles H, Walker RL, Anzick S, Zeillinger R, Meltzer P and Theillet C . (1998). Clin. Cancer. Res., 4, 2925–2929.

  • Beatson GT . (1896). Lancet, ii, 104–107.

  • Beckmann R, Buchner K, Jungblut PR, Eckerskorn C, Weise C, Hilbert R and Hucho F . (1992). Eur. J. Biochem., 210, 45–51.

  • Berger T, Brigl M, Herrmann JM, Vielhauer V, Luckow B, Schlondorff D and Kretzler M . (2000). J. Cell Sci., 113 (Part 20), 3603–3612.

  • Bishop CM and Tipping ME . (1998). IEEE Trans. Pattern Anal. Mach. Intell., 20, 281–293.

  • Biswas DK, Cruz AP, Gansberger E and Pardee AB . (2000). Proc. Natl. Acad. Sci. USA, 97, 8542–8547.

  • Biswas DK, Reddy PV, Pickard M, Makkad B, Pettit N and Pardee AB . (1998). J. Biol. Chem., 273, 33817–33824.

  • Bocker T, Bittinger W, Buettner R, Fauser R, Hofstaedter F and Rüschoff J . (1995). Mod. Pathol., 8, 226–231.

  • Boudreau N, Sympson CJ, Werb Z and Bissell MJ . (1995). Science, 267, 891–893.

  • Bouker KB and Hilakivi-Clarke L . (2000). Environ. Health Persp., 108, 701–708.

  • Bouker KB, Skaar TC, Fernandez D and Clarke R . (2002). Proc. Am. Assoc. Cancer Res., 43, 761.

  • Bouras T, Southey MC and Venter DJ . (2001). Cancer Res., 61, 903–907.

  • Bours V, Bentires-Alj M, Hellin AC, Viatour P, Robe P, Delhalle S, Benoit V and Merville MP . (2000). Biochem. Pharmacol., 60, 1085–1089.

  • Bowers JL, Tyulmenkov VV, Jernigan SC and Klinge CM . (2000). Endocrinology, 141, 3657–3667.

  • Bradlow HL, Sepkovic DW, Telang NT and Osborne MP . (1999). Ann. N. Y. Acad. Sci., 889, 204–213.

  • Brankin B, Skaar TC, Trock BJ, Berris M and Clarke R . (1998). Cancer Epidemiol. Biomarkers Prev., 7, 1109–1115.

  • Brünner N, Boulay V, Fojo A, Freter C, Lippman ME and Clarke R . (1993a). Cancer Res., 53, 283–290.

  • Brünner N, Boysen B, Jirus S, Skaar TC, Holst-Hansen C, Lippman J, Frandsen T, Spang-Thomsen M, Fuqua SAW and Clarke R . (1997). Cancer Res., 57, 3486–3493.

  • Brünner N, Frandsen TL, Holst-Hansen C, Bei M, Thompson EW, Wakeling AE, Lippman ME and Clarke R . (1993b). Cancer Res., 53, 3229–3232.

  • Brzozowski AM, Pike AC, Dauter Z, Hubbard RE, Bonn T, Engstrom O, Ohman L, Greene GL, Gustafsson J-A and Carlquist M . (1997). Nature, 389, 753–758.

  • Buckely MMT and Goa KL . (1989). Drugs, 37, 451–490.

  • Burow ME, Weldon CB, Tang Y, Navar GL, Krajewski S, Reed JC, Hammond TG, Clejan S and Beckman BS . (1998). Cancer Res., 58, 4940–4946.

  • Buzdar A and Howell A . (2001). Clin. Cancer Res., 7, 2620–2635.

  • Buzdar A, Jonat W, Howell A, Jones SE, Blomqvist C, Vogel CL, Eiermann W, Wolter JM, Azab M, Webster A and Plourde PV . (1996). J. Clin. Oncol., 14, 2000–2011.

  • Byrne GJ, Ghellal A, Iddon J, Blann AD, Venizelos V, Kumar S, Howell A and Bundred NJ . (2000). J. Natl. Cancer Inst., 92, 1329–1336.

  • Carroll JS, Swarbrick A, Musgrove EA and Sutherland RL . (2002). Cancer Res., 62, 3126–3131.

  • Castro-Rivera E, Samudio I and Safe S . (2001). J. Biol. Chem., 276, 30853–30861.

  • Cavalieri EL and Rogan EG . (2002). Ann. N. Y. Acad. Sci., 959, 341–354.

  • Cavalieri EL, Stack DE, Devanesan PD, Todorovic R, Dwivedy I, Higginbotham S, Johansson SL, Patil KD, Gross ML, Gooden JK, Ramanathan R, Cerny RL and Rogan EG . (1997). Proc. Natl. Acad. Sci. USA, 94, 10937–10942.

  • CGHFBC—Collaborative Group on Hormonal Factors in Breast Cancer. (1996). Lancet, 347, 1713–1727.

  • Chan CM, Lykkesfeldt AE, Parker MG and Dowsett M . (1999). Clin. Cancer Res., 5, 3460–3467.

  • Chan TW, Pollak M and Huynh H . (2001). Clin. Cancer Res., 7, 2545–2554.

  • Chapman NR and Perkins ND . (2000). J. Biol. Chem., 275, 4719–4725.

  • Chlebowski RT, Col N, Winer EP, Collyar DE, Cummings SR, Vogel III VG, Burstein HJ, Eisen A, Lipkus I and Pfister DG . (2002). J. Clin. Oncol., 20, 3328–3343.

  • Chow W, Fang J and Yee J . (2000). J. Immunol., 164, 3512–3518.

  • Clark GJ and Der CJ . (1995). Breast Cancer Res. Treat., 35, 133–144.

  • Clarke R and Brünner N . (1995). Endocr. Relat. Cancer, 2, 59–72.

  • Clarke R and Brünner N . (1996). Trends Endocrinol. Metab., 7, 25–35.

  • Clarke R, Brünner N, Katzenellenbogen BS, Thompson EW, Norman MJ, Koppi C, Paik S, Lippman ME and Dickson RB . (1989a). Proc. Natl. Acad. Sci. USA, 86, 3649–3653.

  • Clarke R, Brünner N, Thompson EW, Glanz P, Katz D, Dickson RB and Lippman ME . (1989b). J. Endocrinol., 122, 331–340.

  • Clarke R, Currier S, Kaplan O, Lovelace E, Boulay V, Gottesman MM and Dickson RB . (1992). J. Natl. Cancer Inst., 84, 1506–1512.

  • Clarke R, Dickson RB and Brünner N . (1990a). Ann. Oncol., 1, 401–407.

  • Clarke R, Hilakivi-Clarke LA and Trock B . (2001a). Biologist, 48, 21–26.

  • Clarke R, Leonessa F, Welch JN and Skaar TC . (2001b). Pharmacol. Rev., 53, 25–71.

  • Clarke R and Lippman ME . (1992). Drug Resistance in Oncology. Teicher BA (ed). Marcel Dekker, Inc.: New York, pp. 501–536.

    Google Scholar 

  • Clarke R, Skaar TC, Bouker KB, Davis N, Lee YR, Welch JN and Leonessa F . (2001c). J. Steroid Biochem. Mol. Biol., 76, 71–84.

  • Clarke R, van den Berg HW and Murphy RF . (1990b). J. Natl. Cancer Inst., 82, 1702–1705.

  • Clarke SD, Gasperikova D, Nelson C, Lapillonne A and Heird WC . (2002). Ann. N. Y. Acad. Sci., 967, 283–298.

  • Clarkson RW and Watson CJ . (1999). J. Mammary Gland Biol. Neoplasia, 4, 165–175.

  • Clarysse A . (1985). Eur. J. Cancer Clin. Oncol., 21, 545–547.

  • Clauss IM, Chu M, Zhao JL and Glimcher LH . (1996). Nucleic Acids Res., 24, 1855–1864.

  • Coccia EM, Del Russo N, Stellacci E, Orsatti R, Benedetti E, Marziali G, Hiscott J and Battistini A . (2000). Oncogene, 18, 2129–2137.

  • Cogswell PC, Guttridge DC, Funkhouser WK and Baldwin Jr AS . (2000). Oncogene, 19, 1123–1131.

  • Cole MP, Jones CTA and Todd IDH . (1971). Br. J. Cancer, 25, 270–275.

  • Collins BM, McLachlan JA and Arnold SF . (1997). Steroids, 62, 365–372.

  • Colombo E, Marine JC, Danovi D, Falini B and Pelicci PG . (2002). Nat. Cell Biol., 4, 529–533.

  • Connor CE, Norris JD, Broadwater G, Willson TM, Gottardis MM, Dewhirst MW and McDonnell DP . (2001). Cancer Res., 61, 2917–2922.

  • Contente S, Kenyon K, Sriraman P, Subramanyan S and Friedman RM . (1999). Mol. Cell. Biochem., 194, 79–91.

  • Conze D, Weiss L, Regen PS, Bhushan A, Weaver D, Johnson P and Rincon M . (2001). Cancer Res., 61, 8851–8858.

  • Cordon-Cardo C, O'Brien JP, Casals D, Rittman-Grauer L, Biedler JL, Melamed MR and Bertino JR . (1989). Proc. Natl. Acad. Sci. USA, 86, 695–698.

  • Cummings SR, Eckert S, Krueger KA, Grady D, Powles TJ, Cauley JA, Norton L, Nickelsen T, Bjarnson NH, Morrow M, Lippman ME, Black D, Glusman JE, Costa A and Jordan VC . (1999). J. Am. Med. Assoc., 281, 2189–2197.

  • Cuny M, Kramar A, Courjal F, Johannsdottir V, Iacopetta B, Fontaine H, Grenier J, Culine S and Theillet C . (2000). Cancer Res., 60, 1077–1083.

  • Dai P, Clarke R and Wong L-J . (2003), Submitted.

  • Das A, Chendil D, Dey S, Mohiuddin M, Milbrandt JD, Rangnekar VM and Ahmed MM . (2001). J. Biol. Chem., 276, 3279–3286.

  • Dauvois S, Danielian PS, White R and Parker MG . (1992). Proc. Natl. Acad. Sci. USA, 89, 4037–4041.

  • Davies GC, Huster WJ, Lu Y, Plouffe L and Lakshmanan M . (1999). Obstet. Gynecol., 93, 558–565.

  • Day R, Ganz PA, Costantino JP, Cronin WM, Wickerham DL and Fisher B . (1999). J. Clin. Oncol., 17, 2659–2669.

  • DeGraffenried LA, Friedrichs WE, Fulcher L, Fernandes G, Silva JM, Peralba J-M and Hidalgo M . (2003). Ann. Oncol., 14, 1051–1056.

  • De Vincenzo R, Scambia G, Benedetti PP, Fattorossi A, Bonanno G, Ferlini C, Isola G, Pernisco S and Mancuso S . (1996). Int. J. Cancer, 68, 340–348.

  • Delgado M, Munoz-Elias EJ, Gomariz RP and Ganea D . (1999). J. Immunol., 162, 4685–4696.

  • Depypere HT, Bracke ME, Boterberg T, Mareel MM, Nuytinck M, Vennekens K and Serreyn R . (2000). Eur. J. Cancer, 36(Suppl. 4), S73.

  • Dickson RB and Lippman ME . (1995). Endocr. Rev., 16, 559–589.

  • Doherty GM, Boucher L, Sorenson K and Lowney J . (2001). Ann. Surg., 233, 623–629.

  • Dotzlaw H, Leygue E, Watson PH and Murphy LC . (1999). Cancer Res., 59, 529–532.

  • Dowsett M . (1997). J. Steroid Biochem. Mol. Biol., 61, 261–266.

  • Drew PD, Franzoso G, Becker KG, Bours V, Carlson LM, Siebenlist U and Ozato K . (1995). J. Interferon Cytokine Res., 15, 1037–1045.

  • Dumont JA, Bitoni AJ, Wallace CD, Baumann RJ, Cashman EA and Cross-Doersen DE . (1996). Cell Growth Differ., 7, 351–359.

  • EBCTCG—Early Breast Cancer Trialist's Collaborative Group. (1992). Lancet, 399, 1–15.

  • EBCTCG—Early Breast Cancer Trialist's Collaborative Group. (1998). Lancet, 351, 1451–1467.

  • Egeblad M and Jaattela M . (2000). Int. J. Cancer, 86, 617–625.

  • EHBCCG—Endogenous Hormones and Breast Cancer Collaborative Group. (2002). J. Natl. Cancer Inst., 94, 606–616.

  • Ellis M, Davis N, Coop A, Liu M, Schumaker L, Lee RY, Srikanchana R, Russell CG, Singh B, Miller WR, Stearns V, Pennanen M, Tsangaris T, Gallagher A, Liu A, Zwart A, Hayes DF, Lippman ME, Wang Y and Clarke R . (2002). Clin. Cancer Res., 8, 1155–1166.

  • Ellis MJ, Coop A, Singh B, Mauriac L, Llombert-Cussac A, Janicke F, Miller WR, Evans DB, Dugan M, Brady C, Quebe-Fehling E and Borgs M . (2001). J. Clin. Oncol., 19, 3808–3816.

  • Encarnacion CA, Ciocca DR, McGuire WL, Clark GM, Fuqua SA and Osborne CK . (1993). Breast Cancer Res. Treat., 26, 237–246.

  • Escalante CR, Yie J, Thanos D and Aggarwai AK . (1998). Nature, 391, 103–106.

  • Etienne MC, Milano G, Fischcel JL, Frenay M, Francois E, Formento JL, Gioanni J and Namer M . (1989). Br. J. Cancer, 60, 30–35.

  • Fattman CL, An B, Sussman L and Dou QP . (1998). Cancer Lett., 130, 103–113.

  • Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov M, Atkins J, Daly M, Wieand S, Tan-Chiu E, Ford L and Wolmark N . (1998). J. Natl. Cancer Inst., 90, 1371–1388.

  • Freedman M, San Martin J, O'Gorman J, Eckert S, Lippman ME, Lo SC, Walls EL and Zeng J . (2001). J. Natl. Cancer Inst., 93, 51–56.

  • Friedrich K, Wieder T, Von Haefen C, Radetzki S, Janicke R, Schulze-Osthoff K, Dorken B and Daniel PT . (2001). Oncogene, 20, 2749–2760.

  • Fuqua SA . (2001). J. Mammary Gland Biol. Neoplasia, 6, 407–417.

  • Garcia-Pineres AJ, Castro V, Mora G, Schmidt TJ, Strunck E, Pahl HL and Merfort I . (2001). J. Biol. Chem., 276, 39713–39720.

  • Glaeser M, Floetotto T, Hanstein B, Beckmann MW and Niederacher D . (2001). Horm. Metab. Res., 33, 121–126.

  • Goss PE, Clark RM, Ambus U, Weizel HA, Wadden NA, Crump M, Walde D, Tye LM, De Coster R and Bruynseels J . (1995). Clin. Cancer Res., 1, 287–294.

  • Gottardis MM, Wagner RJ, Borden EC and Jordan VC . (1989). Cancer Res., 49, 4765–4769.

  • Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, Hsia J, Hulley S, Herd A, Khan S, Newby LK, Waters D, Vittinghoff E and Wenger N . (2002). J. Am. Med. Assoc., 288, 49–57.

  • Graham JD, Bain DL, Richer JK, Jackson TA, Tung L and Horwitz KB . (2000). J. Steroid Biochem. Mol. Biol., 74, 255–259.

  • Gu Z, Hanfelt J, Hurley C and Clarke R . (1997). Proc. Am. Assoc. Cancer Res., 38, 573.

  • Gu Z, Lee RY, Skaar TC, Bouker KB, Welch JN, Lu J, Liu A, Zhu Y, Davis N, Leonessa F, Brunner N, Wang Y and Clarke R . (2002). Cancer Res., 62, 3428–3437.

  • Gundimeda U, Chen Z-H and Gopalakrishna R . (1996). J. Biol. Chem., 271, 13504–13514.

  • Hardman WE, Avula CP, Fernandes G and Cameron IL . (2001). Clin. Cancer Res., 7, 2041–2049.

  • Harris HA, Bapat AR, Gonder DS and Frail DE . (2002). Steroids, 67, 379–384.

  • Hehner SP, Hofmann TG, Droge W and Schmitz ML . (1999). J. Immunol., 163, 5617–5623.

  • Herbst AL, Griffiths CT and Kistner RW . (1964). Cancer Chemother. Rep., 443, 39–41.

  • Herrera JE, Savkur R and Olson MOJ . (1995). Nucleic Acids Res., 19, 3974–3979.

  • Hilakivi-Clarke L . (2000). Cancer Res., 60, 4993–5001.

  • Hilakivi-Clarke L, Cabanes A, Olivo S, Kerr L, Bouker KB and Clarke R . (2002). J. Steroid Biochem. Mol. Biol., 80, 163–174.

  • Hilakivi-Clarke L, Onojafe I, Raygada M, Cho E, Skaar T, Russo I and Clarke R . (1999a). Br. J. Cancer, 80, 1682–1688.

  • Hilakivi-Clarke LA, Clarke R, Onojafe I, Raygada M, Cho E and Lippman ME . (1997). Proc. Natl. Acad. Sci. USA, 94, 9372–9377.

  • Hilakivi-Clarke LA, Trock B and Clarke R . (1999b). Breast Cancer: Contemporary Cancer Research. Bowcock A (ed). Humana Press: Clifton, pp. 537–568.

    Google Scholar 

  • Hoffman B, Amanullah A, Shafarenko M and Liebermann DA . (2002). Oncogene, 21, 3414–3421.

  • Honig SF . (1996). Diseases of the Breast. Harris JR, Lippman ME, Morrow M, Hellman S (eds). Lippincott-Raven: Philadelphia, pp. 669–734.

    Google Scholar 

  • Hopp TA and Fuqua SA . (1998). J. Mammary Gland Biol. Neoplasia, 3, 73–83.

  • Howell A . (2001). Clin. Cancer Res., 7, 4369s–4375s.

  • Howell A, DeFriend DJ, Robertson JFR, Blamey RW, Anderson L, Anderson E, Sutcliffe FA and Walton P . (1996). Br. J. Cancer, 74, 300–308.

  • Howell A, DeFriend D, Robertson JFR, Blamey RW and Walton P . (1995). Lancet, 345, 29–30.

  • Hsieh C, Pavia M, Lambe M, Lan SJ, Colditz GA, Ekbom A, Adami HO, Trichopoulos D and Willett WC . (1994). Eur. J. Cancer, 30A, 969–973.

  • Hsieh C-Y, Santell RC, Haslam SZ and Helferich WG . (1998). Cancer Res., 58, 3833–3844.

  • Huang RP, Fan Y, de I B, Niemeyer C, Gottardis MM, Mercola D and Adamson ED . (1997). Int. J. Cancer, 72, 102–109.

  • Hulka BS and Stark AT . (1995). Lancet, 346, 883–887.

  • Hulley S, Grady D, Bush T, Herrington D, Riggs B and Vittinghoff E . (1998). J. Am. Med. Assoc., 280, 605–613.

  • Huovinen R, Warri A and Collan Y . (1993). Int. J. Cancer, 55, 685–691.

  • Hwang PL . (1987). Biochem. J., 243, 359–364.

  • Inouye CJ and Seto E . (1994). J. Biol. Chem., 269, 6506–6510.

  • Jackson TA, Richer JK, Bain DL, Takimoto GS, Tung L and Horwitz KB . (1997). Mol. Endocrinol., 11, 693–705.

  • Jiang PS and Yung BY . (1999). Biochem. Biophys. Res. Commun., 257, 865–870.

  • Jiang SY, Langan-Fahey SM, Stella AL, McCague R and Jordan VC . (1992). Mol. Endocrinol., 6, 2167–2174.

  • Joensuu H, Holli K, Oksanen H and Valavaara R . (2000). Breast Cancer Res. Treat., 63, 225–234.

  • Johnston SR . (2001). Clin. Cancer Res., 7, 4376s–4387s.

  • Ju YH, Doerge DR, Allred KF, Allred CD and Helferich WG . (2002). Cancer Res., 62, 2474–2477.

  • Karin M, Cao Y, Greten FR and Li ZW . (2002). Nat. Rev. Cancer, 2, 301–310.

  • Karnik PS, Kulkarni S, Liu XP, Budd GT and Bukowski RM . (1994). Cancer Res., 54, 349–353.

  • Katchamart S and Williams DE . (2001). Comp. Biochem. Physiol. C, 129, 377–384.

  • Keane MM, Ettenberg SA, Lowrey GA, Russell EK and Lipkowitz S . (1996). Cancer Res., 56, 4791–4798.

  • Kenny FS, Gee JM, Nicholson RI, Ellis IO, Morris TM, Watson SA, Bryce RP and Robertson JF . (2001). Int. J. Cancer, 92, 342–347.

  • Kim DW, Sovak MA, Zanieski G, Nonet G, Romieu-Mourez R, Lau AW, Hafer LJ, Yaswen P, Stampfer M, Rogers AE, Russo J and Sonenshein GE . (2000). Carcinogenesis, 21, 871–879.

  • Kim MY, Hsiao SJ and Kraus WL . (2001). EMBO J., 20, 6084–6094.

  • Kinsinger LS, Harris R, Woolf SH, Sox HC and Lohr KN . (2002). Ann. Intern. Med., 137, 59–69.

  • Kirchoff S, Wilhelm D, Angel P and Hauser H . (1999). Eur. J. Biochem., 261, 546–554.

  • Kirkman H . (1972). Prog. Exp. Tumor Res., 16, 201–240.

  • Kishimoto T, Kokura K, Ohkawa N, Makino Y, Yoshida M, Hirohashi S, Niwa S, Muramatsu M and Tamura T . (1998). Cell Growth Differ., 9, 337–344.

  • Kistner RW and Smith OW . (1960). Surg. Forum, 10, 725–729.

  • Koh KK, Blum A, Hathaway L, Mincemoyer R, Csako G, Waclawiw MA, Panza JA and Cannon III RO . (1999). Circulation, 100, 1851–1857.

  • Kondo T, Minamino N, Nagamura-Inoue T, Matsumoto M, Taniguchi T and Tanaka N . (1997). Oncogene, 15, 1275–1281.

  • Konecny G, Pauletti G, Pegram M, Untch M, Dandekar S, Aguilar Z, Wilson C, Rong HM, Bauerfeind I, Felber M, Wang HJ, Beryt M, Seshadri R, Hepp H and Slamon DJ . (2003). J. Natl. Cancer Inst., 95, 142–153.

  • Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S and Gustafsson J-A . (1996). Proc. Natl. Acad. Sci, 93, 5925–5939.

  • Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der BB and Gustafsson JA . (1998). Endocrinology, 139, 4252–4263.

  • Kuiper GGJM, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S and Gustafsson J-A . (1997). Endocrinology, 138, 863–870.

  • Kurokawa H, Lenferink AE, Simpson JF, Pisacane PI, Sliwkowski MX, Forbes JT and Arteaga CL . (2000). Cancer Res., 60, 5887–5894.

  • Kuukasjarvi T, Kononen J, Helin H, Holli K and Isola J . (1996). J. Clin. Oncol., 14, 2584–2589.

  • Kyprianou N, English HF, Davidson NE and Isaacs JT . (1991). Cancer Res., 51, 162–166.

  • Lacassagne A . (1932). C. R. Acad. Sci. (Paris), 195, 639–632.

  • Lavinsky RM, Jepsen K, Heinzel T, Torchia J, Mullen T-M, Schiff R, Del-Rio AL, Ricote M, Ngo S, Gemsch J, Hilsenbeck SG, Osborne CK, Glass CK, Rosenfeld MG and Rose DW . (1998). Proc. Natl. Acad. Sci. USA, 95, 2920–2925.

  • Lazennec G, Bresson D, Lucas A, Chauveau C and Vignon F . (2001). Endocrinology, 142, 4120–4130.

  • LeClercq G . (2002). J. Steroid Biochem. Mol. Biol., 80, 259–272.

  • Lee AH, Hong JH and Seo YS . (2000). Biochem. J., 350 (Part 1), 131–138.

  • Lee KC and Lee KW . (2001). Trends Endocrinol. Metab., 12, 191–197.

  • Leygue E, Dotzlaw H, Watson PH and Murphy LC . (1998). Cancer Res., 58, 3197–3201.

  • Liao DJ and Dickson RB . (2000). Endocr. Relat. Cancer, 7, 143–164.

  • Liberopoulos E, Karabina SA, Tselepis A, Bairaktari E, Nicolaides C, Pavlidis N and Elisaf M . (2002). Oncology, 62, 115–120.

  • Lilling G, Nordenberg J, Rotter V, Goldfinger N, Peller S and Sidi Y . (2002). Cancer Invest., 20, 509–517.

  • List HJ, Reiter R, Singh B, Wellstein A and Riegel AT . (2001). Breast Cancer Res. Treat., 68, 21–28.

  • Litherland S and Jackson IM . (1988). Cancer Treat. Rev., 15, 183–194.

  • Liu C, Rangnekar VM, Adamson E and Mercola D . (1998). Cancer Gene Ther., 5, 3–28.

  • Liu H, Park WC, Bentrem DJ, McKian KP, Reyes AL, Loweth JA, Schafer JM, Zapf JW and Jordan VC . (2002a). J. Biol. Chem., 277, 9189–9198.

  • Liu MM, Albanese C, Anderson CM, Hilty K, Webb P, Uht RM, Price Jr RH, Pestell RG and Kushner PJ . (2002b). J. Biol. Chem., 277, 24353–24360.

  • Liu WH, Hsu CY and Yung BY . (1999). Int. J. Cancer, 83, 765–771.

  • Love RR . (1989). J. Clin. Oncol., 7, 803–815.

  • Lu LJ, Anderson KE, Grady JJ, Kohen F and Nagamani M . (2000). Cancer Res., 60, 4112–4121.

  • Luboshits G, Shina S, Kaplan O, Engelberg S, Nass D, Lifshitz-Mercer B, Chaitchik S, Keydar I and Ben Baruch A . (1999). Cancer Res., 59, 4681–4687.

  • Magnusson C, Baron JA, Correia N, Bergstrom R, Adami HO and Persson I . (1999). Int. J. Cancer, 81, 339–344.

  • Mandlekar S, Hebbar V, Christov K and Kong AN . (2000a). Cancer Res., 60, 6601–6606.

  • Mandlekar S, Yu R, Tan TH and Kong AN . (2000b). Cancer Res., 60, 5995–6000.

  • Martin MB, Franke TF, Stoica GE, Chambon P, Katzenellenbogen BS, Stoica BA, McLemore MS, Olivo SE and Stoica A . (2000). Endocrinology, 141, 4503–4511.

  • Martin PM, Horwitz KB, Ryan DS and McGuire WL . (1978). Endocrinology, 103, 1860–1867.

  • Maruyama S, Fujimoto N, Asano K and Ito A . (2001a). J. Steroid Biochem. Mol. Biol., 78, 177–184.

  • Maruyama S, Fujimoto N, Asano K and Ito A . (2001b). J. Steroid Biochem. Mol. Biol., 78, 177–184.

  • McCormick DL and Moon RC . (1986). Carcinogenesis, 7, 193–196.

  • McKenna NJ, Lanz RB and O'Malley BW . (1999). Endocr. Rev., 20, 321–344.

  • McKenna NJ and O'Malley BW . (2002). Endocrinology, 143, 2461–2465.

  • McMichael-Phillips DF, Harding C, Morton M, Robert SA, Howell A, Potten CS and Bundred NJ . (1998). Am. J. Clin. Nutr., 68, 1431S–1436S.

  • Messina M, Persky V, Setchell KDR and Barnes S . (1994). Nutr. Cancer, 21, 113–131.

  • Miller MA, Greene GL and Katzenellenbogen BS . (1984). Endocrinology, 114, 296–298.

  • Mirnikjoo B, Brown SE, Kim HF, Marangell LB, Sweatt JD and Weeber EJ . (2001). J. Biol. Chem., 276, 10888–10896.

  • Molino A, Micciolo R, Bonetti F, Piubello Q, Corgnati A, Sperotto L, Recaldin E, Spagnolli P, Manfrin E, Bonetti A, Nortilli R, Tomezzoli A, Pollini GP, Modena S and Cetto GL . (1997). Breast Cancer Res. Treat., 45, 241–249.

  • Montano MM and Katzenellenbogen BS . (1997). Proc. Natl. Acad. Sci. USA, 94, 2581–2586.

  • Mori K, Stone S, Khaodhiar L, Braverman LE and DeVito WJ . (1999). J. Cell Biochem., 74, 211–219.

  • Moro A, Santos A, Arana MJ and Perea SE . (2000). Biochem. Biophys. Res. Commun., 269, 31–34.

  • Murphy LC, Dotzlaw H, Leygue E, Coutts A and Watson P . (1998). J. Steroid Biochem. Mol. Biol., 65, 175–180.

  • Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet RJ and Sledge GW . (1997). Mol. Cell. Biol., 17, 3629–3639.

  • Nardulli AM, Grobner C and Cotter D . (1995). Mol. Endocrinol., 9, 1064–1076.

  • National Toxicology Program. (2002). 10th Report on Carcinogens, US Department of Health and Human Services, December.

  • Neish AS, Read MA, Thanos D, Pine R, Maniatis T and Collins T . (1995). Mol. Cell. Biol., 15, 2558–2569.

  • Nicholson RI, Hutcheson IR, Harper ME, Knowlden JM, Barrow D, McClelland RA, Jones HE, Wakeling AE and Gee JM . (2001). Endocr. Relat. Cancer, 8, 175–182.

  • Nishizuka Y . (1992). Science, 258, 607–614.

  • Nomura Y, Tashiro H and Hisamatsu K . (1990). J. Natl. Cancer Inst., 82, 1146–1149.

  • Nozawa H, Oda E, Nakao K, Ishihara M, Ueda S, Yokochi T, Ogasawara K, Nakatsuru Y, Hioki K, Aizawa S, Ishikawa T, Katsuki M, Muto T, Taniguchi T and Tanaka N . (1999). Genes Dev., 1-3, 1240–1245.

  • Nozawa Y, van Belzen N, van der Made ACJ, Dinjens WNM and Bosman FT . (1996). J. Pathol., 178, 48–52.

  • O'Brian CA, Liskamp RM, Solomon DH and Weinstein IB . (1986). J. Natl. Cancer Inst., 76, 1243–1246.

  • Okubo T, Nagai F, Ushiyama K, Yokoyama Y, Ozawa S, Kano K, Tomita S, Kubo H and Kano I . (1998). Cancer Lett., 122, 9–15.

  • Osborne CK, Bardou V, Hopp TA, Chamness GC, Hilsenbeck SG, Fuqua SAW, Wong J, Allred DC, Clark GM and Schiff R . (2003). J. Natl. Cancer Inst., 95, 353–361.

  • Osborne CK, Coronado EB and Robinson JP . (1987). Eur. J. Cancer Clin. Oncol., 23, 1189–1196.

  • Paech K, Webb P, Kuiper GG, Nilsson S, Gustafsson J-A, Kushner PJ and Scanlan TS . (1997). Science, 277, 1508–1510.

  • Patel NM, Nozaki S, Shortle NH, Bhat-Nakshatri P, Newton TR, Rice S, Gelfanov V, Boswell SH, Goulet Jr RJ, Sledge Jr GW and Nakshatri H . (2000). Oncogene, 19, 4159–4169.

  • Perez-Tenorio G and Stal O . (2002). Br. J. Cancer, 86, 540–545.

  • Perou CM, Sorlie T, Eisen MB, Van de RM, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO and Botstein D . (2000). Nature, 406, 747–752.

  • Peter M, Nakagawa J, Doree M, Labbe JC and Nigg EA . (1990). Cell, 60, 791–801.

  • Petrakis NL, Barnes S, King EB, Lowenstein J, Wiencke J, Lee MM, Miike R, Kirk M and Coward L . (1996). Cancer Epidemiol. Biomarkers Prev., 5, 785–794.

  • Pettersson K, Grandien K, Kuiper GG and Gustafsson JA . (1997). Mol. Endocrinol., 11, 1486–1496.

  • Pike AC, Brzozowski AM, Hubbard RE, Bonn T, Thorsell AG, Engstrom O, Ljunggren J, Gustafsson JA and Carlquist M . (1999). EMBO J., 18, 4608–4618.

  • Planas-Silva MD, Shang Y, Donaher JL, Brown M and Weinberg RA . (2001). Cancer Res., 61, 3858–3862.

  • Plotkin D, Lechner JJ, Jung WE and Rosen PJ . (1978). J. Am. Med. Assoc., 240, 2644–2646.

  • Powles T, Eeles R, Ashley S, Easton D, Chang J and Dowsett M . (1998). Lancet, 352, 98–101.

  • Pyrhonen S, Ellmen J, Vuorinen J, Gershanovich M, Tominaga T, Kaufmann M and Hayes DF . (1999). Breast Cancer Res. Treat., 56, 133–143.

  • Raught B, Khursheed B, Kazansky A and Rosen J . (1994). Mol. Cell. Biol., 14, 1752–1763.

  • Reckless J, Metcalfe JC and Grainger DJ . (1997). Circulation, 95, 1542–1548.

  • Reimold AM, Etkin A, Clauss I, Perkins A, Friend DS, Zhang J, Horton HF, Scott A, Orkin SH, Byrne MC, Grusby MJ and Glimcher LH . (2000). Genes Dev., 14, 152–157.

  • Reiter R, Wellstein A and Riegel AT . (2001). J. Biol. Chem., 276, 39736–39741.

  • Robertson JFR . (2001). Br. J. Cancer, 85 (Suppl. 2), 11–14.

  • Roos W, Oeze L, Loser R and Eppenberger U . (1983). J. Natl. Cancer Inst., 71, 55–59.

  • Rowlands MG, Budworth J, Jarman M, Hardcastle IR, McCague R and Gescher A . (1995). Biochem. Pharmacol., 50, 723–726.

  • Rubinstein YR, Proctor KN, Bergel M, Murphy B and Johnson AC . (1998). FEBS Lett., 431, 268–272.

  • Sanceau J, Hiscott J, Delattre O and Wietzerbin J . (2000). Oncogene, 19, 3372–3383.

  • Sanceau J, Kaisho T, Hirano T and Wietzerbin J . (1995). J. Biol. Chem., 270, 27920–27931.

  • Santell RC, Chang YC, Nair MG and Helferich WG . (1997). J. Nutr., 127, 263–269.

  • Santen RJ, Song RX, McPherson R, Kumar R, Adam L, Jeng MH and Yue W . (2002). J. Steroid Biochem. Mol. Biol., 80, 239–256.

  • Saunders PT, Millar MR, Williams K, Macpherson S, Bayne C, O'Sullivan C, Anderson TJ, Groome NP and Miller WR . (2002). Br. J. Cancer, 86, 250–256.

  • Schairer C, Gail M, Byrne C, Rosenberg PS, Sturgeon SR, Brinton LA and Hoover RN . (1999). J. Natl. Cancer Inst., 91, 264–270.

  • Schairer C, Lubin J, Troisi R, Sturgeon S, Brinton L and Hoover R . (2000). J. Am. Med. Assoc., 283, 485–491.

  • Schiff R, Reddy P, Ahotupa M, Coronado-Heinsohn E, Grim M, Hilsenbeck SG, Lawrence R, Deneke S, Herrera R, Chamness GC, Fuqua SA, Brown PH and Osborne CK . (2000). J. Natl. Cancer Inst., 92, 1926–1934.

  • Schinkel AH, Roelofs EM and Borst P . (1991). Cancer Res., 51, 2628–2635.

  • Schwartz JA, Zhong L, Deighton-Collins S, Zhao C and Skafar DF . (2002). J. Biol. Chem., 277, 13202–13209.

  • Sers C, Husmann K, Nazarenko I, Reich S, Wiechen K, Zhumabayeva B, Adhikari P, Schroder K, Gontarewicz A and Schafer R . (2002). Oncogene, 21, 2829–2839.

  • Sheen-Chen SM, Chen WJ, Eng HL and Chou FF . (1997). Breast Cancer Res. Treat., 43, 211–215.

  • Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, Agard DA and Greene GL . (1999). Cell, 95, 927–937.

  • Shiau AK, Barstad D, Radek JT, Meyers MJ, Nettles KW, Katzenellenbogen BS, Katzenellenbogen JA, Agard DA and Greene GL . (2002). Nat. Struct. Biol., 9, 359–364.

  • Skaar TC, Bouker KB and Clarke R . (2000). Proc. Am. Assoc. Cancer Res., 41, 428.

  • Skaar TC, Prasad SC, Sharaeh S, Lippman ME, Brunner N and Clarke R . (1998). J. Steroid Biochem. Mol. Biol., 67, 391–402.

  • Smith CL, DeVera DG, Lamb DJ, Nawaz Z, Jiang YH, Beaudet AL and O'Malley BW . (2002). Mol. Cell. Biol., 22, 525–535.

  • Smith CL, Nawaz Z and O'Malley BW . (1997). Mol. Endocrinol., 11, 657–666.

  • Smith CL, Onate SA, Tsai M-J and O'Malley BW . (1996). Proc. Natl. Acad. Sci. USA, 93, 8884–8888.

  • Sovak MA, Bellas RE, Kim DW, Zanieski GJ, Rogers AE, Traish AM and Sonenshein GE . (1997). J. Clin. Invest., 100, 2952–2960.

  • Speirs V . (2002). J. Pathol., 197, 143–147.

  • Speirs V, Malone C, Walton DS, Kerin MJ and Atkin SL . (1999a). Cancer Res., 59, 5421–5424.

  • Speirs V, Parkes AT, Kerin MJ, Walton DS, Carelton PJ, Fox JN and Atkin SL . (1999b). Cancer Res., 59, 525–528.

  • Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B and Willett WC . (1993). N. Engl. J. Med., 328, 1444–1449.

  • Stewart HJ, Forrest AP, Everington D, McDonald CC, Dewar JA, Hawkins RA, Prescott RJ and George WD . (1996). Br. J. Cancer, 74, 297–299.

  • Suk K, Chang I, Kim Y, Kim S, Kim J, Kim H and Lee M . (2001). J. Biol. Chem., 276, 13153–13159.

  • Tamura T, Ishihara M, Lamphier MS, Tanaka N, Oishi I, Alzawa S, Matsuyama T, Mak TW, Taki S and Taniguchi T . (1995). Nature, 376, 596–599.

  • Tan-Chiu E, Wang J, Costantino JP, Paik S, Butch C, Wickerham DL, Fisher B and Wolmark N . (2003). J. Natl. Cancer Inst., 95, 302–307.

  • Tanaka N, Ishihara M, Kitagawa M, Harada H, Kimura T, Matsuyama T, Lamphier MS, Aizawa S, Mak TW and Taniguchi T . (1994a). Cell, 77, 829–839.

  • Tanaka N, Ishihara M, Lamphier MS, Nozawa H, Matsuyama T, Mak TW, Aizawa S, Tokino T, Oren M and Taniguchi T . (1996). Nature, 382, 816–818.

  • Tanaka N, Ishihara M and Taniguchi T . (1994b). Cancer Lett., 83, 191–196.

  • Taniguchi T . (1997). J. Cell. Physiol., 173, 128–130.

  • Taylor IW, Hodson PJ, Green MD and Sutherland RL . (1983). Cancer Res., 43, 4007–4010.

  • Tchoudakova A, Pathak S and Callard GV . (1999). Gen. Comp. Endocrinol, 113, 388–400.

  • Tebar F, Llado A and Enrich C . (2002). FEBS Lett., 517, 206–210.

  • Toillon RA, Descamps S, Adriaenssens E, Ricort JM, Bernard D, Boilly B and Le BX . (2002). Exp. Cell Res., 275, 31–43.

  • Tokuyama Y, Horn HF, Kawamura K, Tarapore P and Fukasawa K . (2001). J. Biol. Chem., 276, 21529–21537.

  • Tremblay GB, Tremblay A, Labrie F and Giguere V . (1998). Cancer Res., 58, 877–881.

  • Trock B, Butler LW, Clarke R and Hilakivi-Clarke L . (2001). J. Nutr., 130, 690–691.

  • Truss M and Beato M . (1993). Endocr. Rev., 14, 459–479.

  • Tsai JC, Liu L, Guan J and Aird WC . (2000). Am. J. Physiol. Cell Physiol., 279, C1414–C1424.

  • Tyulmenkov VV, Jernigan SC and Klinge CM . (2000). Mol. Cell. Endocrinol., 165, 151–161.

  • Varley CL and Dickson AJ . (1999). Biochem. Biophys. Res. Commun., 263, 627–631.

  • Varma H and Conrad SE . (2002). Cancer Res., 62, 3985–3991.

  • Veronesi U, Maisonneuve P, Costa A, Sacchini V, Maltoni C and Robertson C . (1998). Lancet, 352, 93–97.

  • Veronesi U, Maisonneuve P, Rotmensz N, Costa A, Sacchini V, Travaglini R, D'Aiuto G, Lovison F, Gucciardo G, Muraca MG, Pizzichetta MA, Conforti S, Decensi A, Robertson C and Boyle P . (2003). J. Natl. Cancer Inst., 95, 160–165.

  • Viscoli CM, Brass LM, Kernan WN, Sarrel PM, Suissa S and Horwitz RI . (2001). N. Engl. J. Med., 345, 1243–1249.

  • Voegel JJ, Heine MJ, Zechel C, Chambon P and Gronemeyer H . (1996). EMBO J., 15, 3667–3675.

  • Wang CY, Mayo MW and Baldwin Jr AS . (1996a). Science, 274, 784–787.

  • Wang D, Baumann A, Szbeni A and Olson MOJ . (1994). J. Biol. Chem., 269, 30994–30998.

  • Wang TT, Sathyamoorthy N and Phang JM . (1996b). Carcinogenesis, 17, 271–275.

  • Welch JN and Clarke R . (2002). Signal, 3, 4–9.

  • Welcsh PL and King MC . (2001). Hum. Mol. Genet., 10, 705–713.

  • WHI—Women's Health Initiative. (2002). J. Am. Med. Assoc., 288, 321–333.

  • Winer EP, Hudis C, Burstein HJ, Chlebowski RT, Ingle JN, Edge SB, Mamounas EP, Gralow J, Goldstein LJ, Pritchard KI, Braun S, Cobleigh MA, Langer AS, Perotti J, Powles TJ, Whelan TJ and Browman GP . (2002). J. Clin. Oncol., 20, 3317–3327.

  • Wurtz JM, Egner U, Heinrich N, Moras D and Mueller-Fahrnow A . (1998). J. Med. Chem., 41, 1803–1814.

  • Xu J, Qiu Y, DeMayo FJ, Tsai SY and O'Malley BW . (1998). Science, 279, 1922–1925.

  • Yang NN, Venugopalan M, Hardikar S and Glasebrook A . (1996). Science, 273, 1222–1225.

  • Ye Q and Bodell WJ . (1996). Carcinogenesis, 17, 1747–1750.

  • Yim JH, Wu SJ, Casey MJ, Norton JA and Doherty GM . (1997). Hokkaido Igaku Zasshi, 71, 509–516.

  • Zava DT and Duwe G . (1997). Nutr. Cancer, 27, 31–40.

  • Zhang GJ, Kimijima I, Onda M, Kanno M, Sato H, Watanabe T, Tsuchiya A, Abe R and Takenoshita S . (1999). Clin. Cancer Res., 5, 2971–2977.

  • Zyad A, Bernard J, Clarke R, Tursz T, Brockhaus M and Chouaib S . (1994). Cancer Res., 54, 825–831.

Download references

Acknowledgements

This work was supported in part by grants R01-CA/AG58022-10, R01-CA 089950-02, P30-CA51008-14, NIH P50-CA58185-10 (Public Health Service) and USAMRMC (Department of Defense) BC980629, BC980586, BC990358, BC010619, and BC010531.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Robert Clarke.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Clarke, R., Liu, M., Bouker, K. et al. Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling. Oncogene 22, 7316–7339 (2003). https://doi.org/10.1038/sj.onc.1206937

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206937

Keywords

This article is cited by

Search

Quick links